Beijing Sinotau International Pharmaceutical Technology Co., Ltd.
PrivateLast Round
Growth Equity
Dec 1, 2024
Est. Valuation
$716.4M
Total Funding Raised
$415.3M
Company Overview
Beijing Sinotau International Pharmaceutical Technology Co., Ltd. is a radiopharmaceutical company that develops and commercializes diagnostic and therapeutic radiopharmaceuticals.
Sector
Healthcare & Life Sciences
Verticals
Clinical Trials, Drug Discovery, Medical Imaging, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Hardware Sales, Revenue Share
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Beijing Sinotau International Pharmaceutical Technology Co., Ltd. Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Beijing Sinotau International Pharmaceutical Technology Co., Ltd. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Growth Equity | Dec 1, 2024 | ||||
| Series E | Jul 3, 2023 | ||||
| Series D Extension | Oct 21, 2021 | ||||
| Series D | Feb 23, 2021 | ||||
| Series C | Jul 1, 2020 | ||||
Series B | Jun 1, 2017 |
Beijing Sinotau International Pharmaceutical Technology Co., Ltd. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| J-One Capital | Series C |
| GF Qianhe Investment | Series E |
| Centurium Capital | Series D Extension |
| 中信金石投资有限公司 | Series E |
| Guoke Jiahe Capital | Series C |
| SDIC Chuangyi Industrial Fund Management | Series E |
| Guangdong Technology Financial Group | Series E |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 1, 2026
Monthly visitors increased 75% MoM.
- Jan 1, 2026
Monthly visitors grew 172% MoM, reaching 3K.
Beijing Sinotau International Pharmaceutical Technology Co., Ltd. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Beijing Sinotau International Pharmaceutical Technology Co., Ltd.'s valuation, stock price, and market status.